<DOC>
	<DOC>NCT02296073</DOC>
	<brief_summary>To observe the efficacy and safety of dexmedetomidine sedation on the patients admitted to the pediatric intensive care unit after surgery.</brief_summary>
	<brief_title>The Efficacy and the Safety of Dexmedetomidine Sedation on the Pediatric Intensive Unit(PICU) Patients.</brief_title>
	<detailed_description />
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1. written informed consent； 2. pediatric patients admitted to intensive care unit after general anesthesia; 3. expected mechanical ventilation time &gt;6 hours; （4）1 months to 16 years old; 1. congenital heart disease, arrhythmias and heart failure; 2. Alanine transaminase（ALT） and (or) Aspartate aminotransferase（AST） level is more than twice the upper limit of normal; 3. Creatinine and (or) Blood urea nitrogen（BUN） is more than the upper limit of normal; 4. central nervous system disease; 5. spinal analgesia or muscle relaxants is used during PICU; 6. the drug that affects the nerve conduction is used in one month; 7. allergy to the test drug or having other contraindications; 8. participated in other studies 30 days prior to admission of PICU;</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Pediatric intensive care unit</keyword>
	<keyword>Sedation</keyword>
	<keyword>Dexmedetomidine</keyword>
	<keyword>mechanical ventilation</keyword>
</DOC>